• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Augmedix Raises $16M to Expand Google Glass in Doctors’ Offices

by Fred Pennic 01/12/2015 1 Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Google Glass Starup Augmedix

Today, Augmedix announced that it has received $16 million in Series A venture funding co-led by the company’s seed investors Emergence Capital and DCM Ventures. Augmedix plans to utilize the capital to expand to expand operations, fuel product development, and establish new partnership initiatives. Augmedix has raised $23 million in total venture funding to date. 

Founded by Stanford grads CEO Ian Shakil and Chief Product Officer Pelu Tran in 2012, Augmedix — a service powered by Google Glass — reclaims the hours physicians spend on the computer entering or retrieving data from electronic health records and refocuses them on what matters most: patient care. The service has a nationwide patient acceptance rating of more than 99%. The company is helping customers across 10 states including five national health systems such as Dignity Health using the Augmedix solution. The company has more than 100 employees in offices worldwide, with 80 in its San Francisco headquarters facility, and plans to significantly expand its workforce in 2015.

Google Glass Augmedix Founder
Ian Shakil, CEO of Augmedix

“This new round of funding demonstrates that Google Glass is thriving in the enterprise space, particularly in healthcare,” said Ian Shakil, CEO of Augmedix. “Demand for and reaction to Augmedix have been extremely strong and positive. We’re proud to be making a real difference in patient satisfaction, doctor satisfaction, and health record accuracy. In terms of economic impact, we’ve repeatedly shown that our service effectively turns three doctors into four.”

Emergence Capital has a strong investing track record in the healthcare technology market. Spain sits on the boards of several leading healthcare IT companies including Doximity and Welltok and previously was a board member at publicly-traded Veeva Systems.

Peter Moran, general partner of DCM Ventures and Augmedix board member, added, “Augmedix is addressing a profound pain point, which grows more acute everyday as widespread EHR adoption is spurred by government mandates for ‘meaningful use.'”

Moran serves on the Board of El Camino Hospital. His firm, DCM Ventures, has invested in other wearable innovations such as Athos and Basis Science as well as pioneering the first venture fund dedicated to the Android ecosystem. 

The startup is a graduate of Rock Health, a San Francisco-based digital health seed fund. Augmedix has established a host of other service partners, including Cooper, Fenwick & West LLP, PLC, Schox, Stanford Venture Studio, and others.

Featured image credit: Augmedix

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Augmedix

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |